Chief Executive Officer
CurrentMedical Funding Professionals (MFP) provides funding solutions to short- and long-term startups and mid-market private and public companies in the Life Sciences industry, including:- BioTech- MedTech- Pharma- Digital HealthWe tailor our solutions to fit the individual needs of companies seeking capital for their operations and growth. With a Regulation A+ offering, we partner with companies to raise capital (up to $75M per year) from both accredited and nonaccredited investors — giving you unprecedented access to both Main Street and Wall Street investors who are passionate about your life-changing and life-saving healthcare innovations. As CEO, I oversee MFP’s Capital Planning Valuation Strategy™ (CPVS). This proprietary process helps us develop a custom, proposed pro forma presentation for your Reg A+ offering. Together, we’ll establish a powerful, forward-looking foundation to effectively implement your desired capital funding strategies while ensuring that control of your company remains with founders and major shareholders — not with VCs or equity investors. It’s the easiest and most efficient way to quickly determine how much capital you need and to identify the fastest, least expensive method to raise funds.With CPVS, you gain digital copies of:- Pro forma capitalization table reflecting the current capitalization structure of the company and the projected capitalization table following potential investments- Pre- and post-money valuations of the company- Selling shareholders analysis, showing how current shareholders can have a limited liquidity event in the Reg A+ offering- Custom marketing plan for promotion of both your company and your offering- Description of the sequential steps in the process ending with a financial offering in spreadsheet form- Synopsis with the steps of the funding process, i.e., the capital cash flow projection beginning with post-registration and ending with receipt of offering proceeds.